SCHEMBL6442552

SCHEMBL6442552

O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2c(-c3ncc[nH]3)ccc(F)c12

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.53
CYP3A4 P08684 3/20 0.49
CYP2C19 P33261 6/20 0.47
CYP2D6 P10635 5/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C8 P10632 1/20 0.47
CYP2B6 P20813 1/20 0.47
KCNH2 Q12809 1/20 0.47
KIT P10721 1/20 0.40
CSNK1A1 P48729 1/20 0.38
TYRO3 Q06418 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
HTR2B P41595 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALOX15 P16050 1/20 0.38
POLB P06746 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6443074 0.89 CYP2C9 (0.55) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6441736 0.86 CYP2C9 (0.53) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6445540 0.85 CYP2C9 (0.48) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6442528 0.85 CYP2C9 (0.51) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6441364 0.85 CYP2C9 (0.53) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6445398 0.85 CYP2C9 (0.55) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6446756 0.84 CYP2C9 (0.51) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6442450 0.84 CYP2C9 (0.51) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6440885 0.84 CYP2C9 (0.47) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6442906 0.84 CYP2C9 (0.54) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299382-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-09-21 EP claimed